Abstract:Abstract Background Lung cancer in very young adults in China aged <30 is on the rise and the clinicopathological characteristics of this unique population are incomplete and are yet to be elucidated. Our study aims to explore the characteristics, trends and distinctive features of lung cancer this age group to provide more information that can aid in developing optimal treatment regimens and improve prognosis for this exclusive age group. Method A retrospective review of 141 lung cancer patients admitted at our hospital from August 2011 to October 2021 was performed. The focused age group in our study was 18-30 years old. The data collected included demographics, tumor pathology, gene mutations, and treatment. Overall survival and prognosis were systematically analyzed. Results From a total of 141 of young lung cancer patients, 139 were included in final analysis. The gender distribution in our series favored female(65.5%), and only 7.2% of the study cohort had a history of smoking. Adenocarcinoma was the most common histological type in our study, presenting 93.5% of all patients. The most common stages at diagnosis was stage I(61.2%) and stage IV(30.2%). Genetic testing was performed in only 24.5% (34/139) of the patients. From the 23/34 patients in our study who tested positive for a genetic mutation, 19 (82.3%) were stage IV. The most common gene mutation was Anaplastic Lymphoma kinase(ALK) rearrangement observed in 13/23 (56.5%) gene mutation positive patients. Among stage IV NSCLC, OS was longer in patients who received targeted therapy, compared to the patients not receiving target therapy: 88 months vs 24 months (95% CI: 0.15-1.0, p=0.0282). Conclusion Lung cancer in the young adult population has particular characteristics (Common in female, non-smoker and adenocarcinoma patients). Higher stages of disease were observed in those with a gene mutation (notably ALK rearrangement). Although the sample size was small, the current data suggests a higher mutation rate in the younger population. These findings have fundamental implications for practice and we propose that all patients under 30 diagnosed with lung cancer should undergo genetic testing so they can receive personalized treatment and therefore achieve better outcomes.

Analysis of the Molecular and Clinicopathologic Features of Surgically Resected Lung Adenocarcinoma in Patients under 40 Years Old.

Clinical Features and Gene Mutations of Lung Cancer Patients 30 Years of Age or Younger

Comparison between young and old patients with lung cancer

Clinicopathologic Characteristics and Prognosis for Young Gastric Adenocarcinoma Patients after Curative Resection

Demographics, Risk Factors and Survival Analysis of Lung Cancer in Young Adults (&lt;30 Years) in China-A Retrospective Cohort Study

The clinical features of breast cancer in young patients

Comprehensive Molecular Characterization of Young Chinese Patients with Lung Adenocarcinoma Identified a Distinctive Genetic Profile.

Comparison of Clinicopathological and Molecular Features Between Young and Old Patients with Lung Cancer.

Clinicopathologic and prognostic studies on young male with lung adenocarcinoma

Comprehensive Analysis of Age‐related Somatic Mutation Profiles in Chinese Young Lung Adenocarcinoma Patients

Analysis of gene mutation status and prognosis in lung cancer patients younger than 35 years old:a retrospective study

The Genomic Landscape of Young and Old Lung Cancer Patients Highlights Age-Dependent Mutation Frequencies and Clinical Actionability in Young Patients

The Analysis of Clinical and Pathological Characteristics of 217 Young Patients with Lung Cancer

Unique Clinicopathological Characteristics and Favorable Prognosis of Young Patients with Non-Small Cell Lung Cancer

Next-generation Sequencing Reveals Age-dependent Genetic Underpinnings in Lung adenocarcinoma

Analysis of clinical and pathological features of young patients with lung cancer

Clinicopathological features and prognosis of young patients with non-small cell lung cancer

Comprehensive Investigation of Mutational Features of Various Lung Adenocarcinoma Histological Subtypes among Chinese Patients.

Clinical retrospective observation of lung cancer between young and elderly patients

Clinical Significance of Age at Diagnosis among Young Non-Small Cell Lung Cancer Patients under 40 Years Old: a Population-Based Study

Clinical and Pathological Features of Pulmonary Carcinoma Patients under 40